ID28088A - Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi - Google Patents

Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi

Info

Publication number
ID28088A
ID28088A IDW20002573A ID20002573A ID28088A ID 28088 A ID28088 A ID 28088A ID W20002573 A IDW20002573 A ID W20002573A ID 20002573 A ID20002573 A ID 20002573A ID 28088 A ID28088 A ID 28088A
Authority
ID
Indonesia
Prior art keywords
declaration
antibody
therapy
Prior art date
Application number
IDW20002573A
Other languages
English (en)
Inventor
Jean-Yves Marcel Paul Bonnefoy
Scott James Crowe
Jonathan Henry Ellis
Nicholas Timothy Rapson
Jean Shearin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID28088A publication Critical patent/ID28088A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW20002573A 1998-05-09 1999-05-07 Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi ID28088A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809839.5A GB9809839D0 (en) 1998-05-09 1998-05-09 Antibody

Publications (1)

Publication Number Publication Date
ID28088A true ID28088A (id) 2001-05-03

Family

ID=10831668

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002573A ID28088A (id) 1998-05-09 1999-05-07 Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi

Country Status (25)

Country Link
US (1) US7008623B1 (id)
EP (1) EP1076701A1 (id)
JP (1) JP2002514421A (id)
KR (1) KR20010043470A (id)
CN (1) CN1308676A (id)
AP (1) AP1547A (id)
AU (1) AU763491B2 (id)
BR (1) BR9910327A (id)
CA (1) CA2328606A1 (id)
EA (1) EA200001041A1 (id)
EE (1) EE200000658A (id)
GB (1) GB9809839D0 (id)
HR (1) HRP20000762A2 (id)
HU (1) HUP0102005A3 (id)
ID (1) ID28088A (id)
IL (1) IL139384A0 (id)
IS (1) IS5696A (id)
NO (1) NO20005632L (id)
NZ (1) NZ507879A (id)
PL (1) PL344019A1 (id)
SK (1) SK16762000A3 (id)
TR (1) TR200003281T2 (id)
WO (1) WO1999058679A1 (id)
YU (1) YU69000A (id)
ZA (1) ZA200006312B (id)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696550B2 (en) 1998-07-23 2004-02-24 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
YU28503A (sh) 2000-10-13 2006-05-25 Biogen Inc. Humanizovana anti-lt-beta-r antitela
US20040151721A1 (en) 2001-10-19 2004-08-05 O'keefe Theresa Humanized anti-CCR2 antibodies and methods of use therefor
AU2003248782A1 (en) * 2002-07-01 2004-01-19 Biogen Idec Ma Inc. Humanized anti-lymphotoxin beta receptor antibodies
AR040778A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina).
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
EP1641826A2 (en) 2003-06-27 2006-04-05 Biogen Idec MA Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
CA2434668A1 (en) * 2003-07-04 2005-01-04 Laurence Mulard Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
MXPA06000176A (es) * 2003-12-10 2006-06-27 Millennium Pharm Inc Anticuerpos anti-ccr2 humanizados y sus metodos de uso.
US7435799B2 (en) * 2004-01-08 2008-10-14 Applied Molecular Evolution TNF-α binding molecules
CN1980957A (zh) 2004-03-23 2007-06-13 比奥根艾迪克Ma公司 受体偶联剂及其治疗用途
WO2006039470A2 (en) * 2004-09-29 2006-04-13 Centocor, Inc. Anti- amyloid antibodies, compositions, methods and uses
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
JP5123197B2 (ja) 2005-11-14 2013-01-16 ライナット ニューロサイエンス コーポレイション カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体およびその使用方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
US7680868B2 (en) * 2005-12-20 2010-03-16 Roche Molecular Systems, Inc. PCR elbow determination by use of a double sigmoid function curve fit with the Levenburg-Marquardt algorithm and normalization
EP1804172B1 (en) * 2005-12-20 2021-08-11 Roche Diagnostics GmbH PCR elbow determination using curvature analysis of a double sigmoid
US20090155255A1 (en) * 2007-09-27 2009-06-18 Biogen Idec Ma Inc. Cd23 binding molecules and methods of use thereof
EP2615115A3 (en) 2007-11-30 2014-01-08 Glaxo Group Limited Antigen-binding constructs
ES2689322T3 (es) 2008-03-04 2018-11-13 Teva Pharmaceuticals International Gmbh Métodos para tratar el dolor crónico
JP2011522792A (ja) 2008-05-06 2011-08-04 グラクソ グループ リミテッド 生物活性薬の封入
CA2753287A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
JP2012518400A (ja) 2009-02-24 2012-08-16 グラクソ グループ リミテッド 多価および/または複数特異的rankl結合性構築物
CA2753332A1 (en) 2009-02-24 2010-09-02 Glaxo Group Limited Antigen-binding constructs
CA2757237A1 (en) 2009-04-01 2010-10-14 Jane Elizabeth Clarkson Anti-il-23 immunoglobulins
WO2010122090A1 (en) 2009-04-24 2010-10-28 Glaxo Group Limited Fgfr1c antibody combinations
EP2470207A1 (en) 2009-08-28 2012-07-04 Rinat Neuroscience Corporation Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
FR2957598B1 (fr) * 2010-03-17 2015-12-04 Lfb Biotechnologies Nouveau peptide signal, et son utilisation pour la production de proteines recombinantes
HUE039412T2 (hu) 2010-11-23 2018-12-28 Glaxo Group Ltd Antigén megkötõ proteinek oncostatin M (OSM) megkötésére
EP2853542A1 (en) 2010-11-24 2015-04-01 Glaxo Group Limited Multispecific antigen binding proteins targeting HGF
US8974782B2 (en) 2011-02-07 2015-03-10 Glaxo Group Limited Treatment of stroke comprising anti-MAG antibodies
DK3415531T3 (da) 2011-05-27 2023-09-18 Glaxo Group Ltd Bcma (cd269/tnfrsf17)-bindende proteiner
WO2014029752A1 (en) 2012-08-22 2014-02-27 Glaxo Group Limited Anti lrp6 antibodies
US10176293B2 (en) 2012-10-02 2019-01-08 Roche Molecular Systems, Inc. Universal method to determine real-time PCR cycle threshold values
JP6224739B2 (ja) 2013-03-15 2017-11-01 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 抗lag−3結合タンパク質
US9777057B2 (en) * 2013-07-10 2017-10-03 Onconox Aps Antibodies to β2-glycoprotein I and therapeutic uses thereof
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
CN111973740A (zh) 2014-03-21 2020-11-24 泰华制药国际有限公司 针对降钙素基因相关肽的拮抗剂抗体及其使用方法
CA2995639A1 (en) 2015-09-02 2017-03-09 Immutep S.A.S. Anti-lag-3 antibodies
JP6935184B2 (ja) * 2016-05-31 2021-09-15 シスメックス株式会社 糖ペプチドと反応するモノクローナル抗体およびその用途
US10479827B2 (en) 2016-05-31 2019-11-19 Sysmex Corporation Monoclonal antibody reacting with glycopeptide, and use thereof
CN109475603B (zh) 2016-06-20 2023-06-13 科马布有限公司 抗pd-l1抗体
SG10201913032TA (en) 2016-09-23 2020-02-27 Teva Pharmaceuticals Int Gmbh Treating refractory migraine
CA3143211A1 (en) 2019-06-26 2020-12-30 Glaxosmithkline Intellectual Property Development Limited Il1rap binding proteins
CN112552403A (zh) * 2020-12-25 2021-03-26 南京英瀚斯生物科技有限公司 一种人源抗人CD23抗体的Fab片段、药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285046B6 (sk) 1991-07-25 2006-05-04 Idec Pharmaceuticals Corporation Chimérna protilátka, ktorá sa špecificky viaže na ľudský antigén, farmaceutický prostriedok s jej obsahom, spôsob jej výroby a použitie
MX9204374A (es) * 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
HU223006B1 (hu) * 1994-10-25 2004-03-01 Glaxo Group Ltd. CD23-hoz kötődő vegyületek
US6011138A (en) * 1997-02-20 2000-01-04 Idec Pharmaceuticals Corporation Gamma-1 anti-human CD23 monoclonal antibodies

Also Published As

Publication number Publication date
CA2328606A1 (en) 1999-11-18
IS5696A (is) 2000-10-31
NZ507879A (en) 2004-02-27
BR9910327A (pt) 2001-01-30
SK16762000A3 (sk) 2001-07-10
PL344019A1 (en) 2001-09-24
TR200003281T2 (tr) 2001-03-21
US7008623B1 (en) 2006-03-07
NO20005632L (no) 2001-01-08
KR20010043470A (ko) 2001-05-25
AU763491B2 (en) 2003-07-24
ZA200006312B (en) 2003-02-26
CN1308676A (zh) 2001-08-15
AP2000001983A0 (en) 2000-12-31
NO20005632D0 (no) 2000-11-08
AU3836799A (en) 1999-11-29
GB9809839D0 (en) 1998-07-08
EE200000658A (et) 2002-04-15
YU69000A (sh) 2003-08-29
HUP0102005A3 (en) 2003-10-28
EA200001041A1 (ru) 2001-06-25
WO1999058679A1 (en) 1999-11-18
JP2002514421A (ja) 2002-05-21
AP1547A (en) 2006-01-13
HRP20000762A2 (en) 2001-06-30
IL139384A0 (en) 2001-11-25
EP1076701A1 (en) 2001-02-21
HUP0102005A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
ID28088A (id) Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi
DE69825451D1 (de) Kanüle mit mehreren leitungen
DE69803087D1 (de) Integrierte einzelchip dualmode raidsteuerung
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
DE69809393D1 (de) Gasabsorption
DE69935516D1 (de) Antikörper mit verbesserter produzierbarkeit
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID22957A (id) Senyawa dan penggunaannya
DE69826299D1 (de) Inhalationsgerät
DE69817390D1 (de) Schalldämpfer
ID24490A (id) Metode untuk menggunakan dan metode pembuatan tabung oven-pijar
DE69816326D1 (de) Katalytischer verbrennungsheizer
ID26599A (id) Turunan triazola dan imidazola
DE69823567D1 (de) Geräuschdämpfer
DE69832764D1 (de) Schalldämpfer
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
DE69941535D1 (de) Katalytische verbrennungseinrichtung
ID23258A (id) Penarik pemberian-menyilang dan metodenya
DE69810858D1 (de) Einlassgeräuschdämpfer
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
DE69824327D1 (de) Inhalationsgerät
DE69840029D1 (de) Katalytischer verbrennungsheizer
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
DE29712035U1 (de) Therapievorrichtung